Sudarshan Pharma IPO description – Incorporated in 2008, Mumbai-based Sudarshan Pharma Industries (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients’ specifications and requirements, they outsource the manufacturing facility from suppliers in India and abroad.
The generic products supplied by the company have wide applications in the paint, food, pharma, and adhesive industries. The company is involved in contract manufacturing, supplying and outsourcing medicines and pharma formulation to hospitals, NGOs, government, and healthcare institutes. SPIL has 100 pharma formulations supplied under the brand name in the form of tablets, capsules, dry powder, dry injections powder, liquids, injections & dry injections.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulations & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customized solutions.
The company has exported to countries like Saudi Arabia, Qatar, Uzbekistan, Bangladesh, Ghana, Georgia, Taiwan, Sultanate of Oman, (Muscat) Dubai, (UAE) & UK.
Promoters of Sudarshan Pharma – Mr. Hemal Vasantrai Mehta & Mr. Sachin Vasantrai Mehta
Sudarshan Pharma IPO Details
| Sudarshan Pharma IPO Dates | 9 – 14 March 2023 |
| Sudarshan Pharma IPO Price | INR 71 – 73 per share |
| Fresh issue | 68,62,400 shares (INR 50.10 crore) |
| Offer For Sale | Nil |
| Total IPO size | 68,62,400 shares (INR 50.10 crore) |
| Minimum bid (lot size) | 1,600 shares (INR 116,800) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | BSE SME |
Sudarshan Pharma Financial Performance
| Â | FY 2020 | FY 2021 | FY 2022 | Q1 FY 2023 |
| Revenue | 147.98 | 193.35 | 357.10 | 105.51 |
| Expenses | 146.28 | 190.15 | 350.37 | 102.89 |
| Net income | 1.28 | 2.67 | 5.30 | 2.25 |
Sudarshan Pharma offers News
- Sudarshan Pharma RHP
- Sudarshan Pharma Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Sudarshan Pharma Valuations & Margins
| FY 2020 | FY 2021 | FY 2022 | |
| EPS | 0.83 | 1.75 | 3.39 |
| PE ratio | – | – | 20.94 – 21.53 |
| RONW (%) | 6.43 | 11.85 | 17.63 |
| NAV | 12.98 | 14.76 | 19.23 |
| ROCE (%) | 22.69 | 30.34 | 35.29 |
| EBITDA (%) | 3.23 | 3.90 | 3.20 |
| Debt/Equity | 1.05 | 1.32 | 1.03 |
Sudarshan Pharma IPO GMP Today
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| 21 Mar 2023 | 5 | – | – |
| 20 Mar 2023 | 5 | – | – |
| 18 Mar 2023 | 5 | – | – |
| 17 Mar 2023 | 5 | – | – |
| 16 Mar 2023 | 5 | – | – |
| 15 Mar 2023 | 5 | – | – |
| 14 Mar 2023 | 5 | – | – |
| 13 Mar 2023 | 3 | – | – |
| 11 Mar 2023 | 3 | – | – |
| 10 Mar 2023 | 3 | – | – |
| 9 Mar 2023 | 5 | – | – |
| 8 Mar 2023 | 5 | – | – |
Sudarshan Pharma IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Total |
| Shares Offered | 521,600 | 1,908,800 | 3,651,200 | 6,081,600 |
| 14 Mar 2023 | 1.01 | 0.81 | 1.20 | 1.06 |
| 13 Mar 2023 | 0.00 | 0.58 | 0.88 | 0.71 |
| 10 Mar 2023 | 0.00 | 0.38 | 0.67 | 0.52 |
| 9 Mar 2023 | 0.00 | 0.37 | 0.47 | 0.40 |
Sudarshan Pharma Offer Lead Manager
GRETEX CORPORATE SERVICES LIMITED
Office No. 13, 1st Floor, New Bansilal Building,
Raja Bahadur Mansion, 9-15, Homi Modi Street,
Fort, Mumbai– 400001, Maharashtra, India
Phone: +91 22 4002 5273 / 96532 49863
Email: [email protected]
Website:Â www.gretexcorporate.com
Sudarshan Pharma Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Telephone: +91 40 6716 2222
Email: [email protected]
Website:Â www.kfintech.com
Sudarshan Pharma Contact Details
SUDARSHAN PHARMA INDUSTRIES LIMITED
301,3rd Floor, Aura Biplex,
Above Kalyan Jewellers S. V. Road,
Borivali (West) Mumbai City Maharashtra 400092
Phone: 022- 022- 42221111
E-mail: [email protected]
Website: www.sudarshanpharma.com
Sudarshan Pharma IPO Allotment Status
Sudarshan Pharma IPO allotment status is now available on the KFin Tech website. Click on this link to get allotment status.
Sudarshan Pharma IPO Dates & Listing Performance
| Sudarshan Pharma IPO Opening Date | 9 March 2023 |
| Sudarshan Pharma IPO Closing Date | 14 March 2023 |
| Finalisation of Basis of Allotment | 17 March 2023 |
| Initiation of refunds | 20 March 2023 |
| Transfer of shares to demat accounts | 21 March 2023 |
| Sudarshan Pharma IPO Listing Date | 22 March 2023 |
| Opening Price on BSE SME | INR 73 per share (no change) |
| Closing Price on BSE SME | INR 69.35 per share (down 5%) |
Sudarshan Pharma IPO FAQs
What is Sudarshan Pharma’s offer size?
Sudarshan Pharma’s offer size is INR 50.10 crore.
What is Sudarshan Pharma IPO Price Band?
Sudarshan Pharma’s public offer price is INR 71 – 73 per share.
What is the lot size of Sudarshan Pharma IPO?
Sudarshan Pharma offers a lot size is 1,600 shares.
What is Sudarshan Pharma IPO GMP today?
Sudarshan Pharma IPO GMP today is INR 5 per share.
What is Sudarshan Pharma kostak rate today?
Sudarshan Pharma’s kostak rate today is NA per application.
What is Sudarshan Pharma Subject to Sauda rate today?
Sudarshan Pharma Subject to Sauda rate today is INR NA per application.
